share_log

Wells Fargo Maintains Overweight on BrightSpring Health, Raises Price Target to $16

Wells Fargo Maintains Overweight on BrightSpring Health, Raises Price Target to $16

富国银行维持对BrightSpring Health的增持,将目标股价上调至16美元
Benzinga ·  05/06 09:52

Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $15 to $16.

富国银行分析师斯蒂芬·巴克斯特维持BrightSpring Health(纳斯达克股票代码:BTSG)增持,并将目标股价从15美元上调至16美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发